Crutchfield Bradford's Form 4 filing
10x Genomics, Inc. (TXG) · filed Dec 15, 2021
- Accession no.
- 0001567619-21-022118
- Filed
- Dec 15, 2021
- Trade date
- Dec 13, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 7 non-derivative transactions and 1 derivative transaction. Open-market sales total $2.37M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Crutchfield BradfordCIK 0001246406 | Officer (Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 13, 2021 | Class A Common Stock | MOption exerciseAcquired | +17,000 | $1.16 | +$19,720 | 60,055 | Direct | |
| Dec 13, 2021 | Class A Common Stock | SSaleDisposed | −1,565 | $137.63F2 | −$215,390.95 | 58,490 | Direct | |
| Dec 13, 2021 | Class A Common Stock | SSaleDisposed | −3,235 | $138.60F3 | −$448,371 | 55,255 | Direct | |
| Dec 13, 2021 | Class A Common Stock | SSaleDisposed | −9,599 | $139.52F4 | −$1,339,252.48 | 45,656 | Direct | |
| Dec 13, 2021 | Class A Common Stock | SSaleDisposed | −1,701 | $140.38F5 | −$238,786.38 | 43,955 | Direct | |
| Dec 13, 2021 | Class A Common Stock | SSaleDisposed | −800 | $141.31F6 | −$113,048 | 43,155 | Direct | |
| Dec 13, 2021 | Class A Common Stock | SSaleDisposed | −100 | $142.47 | −$14,247 | 43,055 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 13, 2021 | Class A Common Stock | MOption exerciseDisposed | −17,000 | $0.00 | $0 | 426,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $137.00 to $137.97. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $138.00 to $138.99. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $139.00 to $139.99. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $140.01 to $140.90. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $141.02 to $141.895. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.